The expression of key proteins was validated in an independent set of samples (containing 32 AD patients, 34 MCI sufferers, and 52 normal aging controls) using ELISA assay, among which the expression of CAP1 and ENO1 was below the detection limits. Here, CAP1 is linked to Alzheimer disease.